Abstract: Conventionally, cavities and cracks are filled with a solder metal which forms brittle phases with a subsequently applied coating, which have a negative effect on the mechanical properties. According to the invention, the components which form brittle phases are removed from the solder metal. The above is achieved, whereby a second material is applied which reacts with said component and which is removed again with the brittle phases, before the coating.

Abstract: Conventionally, cavities and cracks are filled with a solder metal which forms brittle phases with a subsequently applied coating, which have a negative effect on the mechanical properties. According to the invention, the components which form brittle phases are removed from the solder metal. The above is achieved, whereby a second material is applied which reacts with said component and which is removed again with the brittle phases, before the coating.

Abstract: Conventionally, cavities and cracks are filled with a solder metal which forms brittle phases with a subsequently applied coating, which have a negative effect on the mechanical properties. According to the invention, the components which form brittle phases are removed from the solder metal. The above is achieved, whereby a second material is applied which reacts with said component and which is removed again with the brittle phases, before the coating.

Abstract: Conventionally, cavities and cracks are filled with a solder metal which forms brittle phases with a subsequently applied coating, which have a negative effect on the mechanical properties. According to the invention, the components which form brittle phases are removed from the solder metal. The above is achieved, whereby a second material is applied which reacts with said component and which is removed again with the brittle phases, before the coating.

Abstract: The novel esters of a chiral alcohol and a mesogenic carboxylic acid are characterized by the general formula (I) ##STR1## in which the symbols have the following meanings: n denotes 0 or 1,R.sup.1 denotes a straight-chain or branched (C.sub.1 -C.sub.4)alkyl which is unsubstituted or substituted by halogen, in particular fluorine,R.sup.2 denotes unsubstituted or substituted (C.sub.6 -C.sub.18)aryl, cyclo(C.sub.5 -C.sub.12)alkyl or mononuclear or binuclear heteroaryl possessing a five-membered and/or six-membered ring, andMC denotes a molecular radical of a mesogenic monocarboxylic acid MC-OH after elimination of an OH group where n=0, and denotes a molecular radical of a mesogenic dicarboxylic acid HO-MC-OH after elimination of two OH groups where n=1, with the exception of compounds in which n denotes 0, R.sup.1 denotes CH.sub.3, R.sup.

Abstract: The novel esters of a chiral alcohol and a mesogenic carboxylic acid are characterized by the general formula (I) ##STR1## in which the symbols have the following meanings: n denotes 0 or 1,R.sup.1 denotes a straight-chain or branched (C.sub.1 -C.sub.4)alkyl which is unsubstituted or substituted by halogen, in particular fluorine,R.sup.2 denotes unsubstituted or substituted (C.sub.6 -C.sub.18)aryl, cyclo(C.sub.5 -C.sub.12)alkyl or mononuclear or binuclear heteroaryl possessing a five-membered and/or six-membered ring, andMC denotes a molecular radical of a mesogenic monocarboxylic acid MC-OH after elimination of an OH group where n=0, and denotes a molecular radical of a mesogenic dicarboxylic acid HO-MC-OH after elimination of two OH groups where n=1, with the exception of compounds in which n denotes 0, R.sup.1 denotes CH.sub.3, R.sup.

Abstract: Use of compounds or mixtures of compounds which have a chiral, orthogonal, more highly ordered smectic phase in the range of said phase as switching or indicating medium.Compounds which have a chiral, orthogonal, more highly ordered smectic phase, in particular an S.sub.B * or an S.sub.E * phase, can be used in the range of said phase or phases as indicating or switching medium in electro-optical indicating or switching components (devices) which are based on the exploitation of the electroclinic effect.

Abstract: The novel compounds are chiral esters of .alpha.-substituted phenylalkanoic acids and mesogenic hydroxy compounds, the symbols in the general formula (I) ##STR1## being defined as follows: MO=molecular radical of a mesogenic hydroxy compound MOH after removal of one H, the radical MO being expressed by the general formula (II)R.sup.2 --(A.sup.1).sub.n1 --(B--).sub.n2 (A.sup.2).sub.n3 --O (II)whereR.sup.2 =straight-chain or branched (C.sub.1 -C.sub.12)-alkyl, it being possible for one or two non-adjacent CH.sub.2 groups to be replaced by O and/or S atoms, or, if n1=1, also F, Cl, Br, CN or CF.sub.3,A.sup.1, A.sup.2 =independently of one another 1,4-phenylene, diazine-2,5-diyl, diazine-3,6-diyl, 1,4-cyclohexylene, 1,3-dioxane-2,5-diyl, 1,3-dithiane-2,5-diyl or 1,4-bicyclo(2,2,2)octylene, it being possible for these groups also to be at least monosubstituted by F, Cl, Br, CN, CF.sub.3 and/or (C.sub.1 -C.sub.12)-alkyl (one or two non-adjacent CH.sub.

Abstract: The novel compounds are chiral esters formed from .alpha.-substituted carboxylic acids and mesogenic hydroxyl compounds of the general formula (I) ##STR1## in which the symbols have the following meaning: MO=molecular radical of a mesogenic hydroxyl compound MOH after removing an H, the radial MO being expressed by the general formula (II):R.sup.2 --(A.sup.1).sub.n1 --(B--).sub.n2 (A.sup.2).sub.n3 --O(II)where the meaning ofR.sup.2 is a straight-chain or branched (C.sub.1 -C.sub.12)alkyl or alkenyl, it being possible for one or two nonadjacent CH.sub.2 groups to be replaced by O and/or S atoms, or if n1=1, also F, Cl, Br or CN,A.sup.1, A.sup.2 are, independently of each other, 1,4-phenylene, pyrimidine-2,5-diyl, 1,4-cyclohexylene, 1,3-dioxane-2,5-diyl, 1,3-dithiane-2,5-diyl, or 1,4-bicyclo(2,2,2)octylene, it being possible for said groups to be substituted at least singly by F, Cl, Br, CN and/or (C.sub.1 -C.sub.12)alkyl (optionally, one or two nonadjacent CH.sub.